Vedanta Biosciences Receives Award from the Crohn’s & Colitis Foundation to Advance a Microbiome-Derived Therapeutic Program for Interception and Treatment of Inflammatory Bowel Disease 글 내용 전체보기
Takeda Receives Clearance from the United States Federal Trade Commission for the Proposed Acquisition of Shire plc 글 내용 전체보기
ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-oncology Contract Development and Manufacturing Project 글 내용 전체보기
Former Rockwell Medical CEO Files Lawsuit, Company Files Counter Lawsuit in Ongoing Legal Battle 글 내용 전체보기
FDA’s Approval of T2 Biosystems T2Bacteria Panel Underlines Importance of Sepsis Diagnosis and Treatment 글 내용 전체보기
